Literature DB >> 3032613

Comparative in vitro activity of LY146032 (daptomycin) against gram-positive cocci.

K Machka, I Braveny.   

Abstract

The in vitro activity of LY146032 was compared with those of seven other antimicrobial agents against gram-positive cocci. MICs of LY146032 were lowest for Streptococcus pneumoniae and methicillin-susceptible Staphylococcus epidermidis (0.25 mg/l). For methicillin-resistant Staphylococcus epidermidis and Staphylococcus aureus the MICs were 1 mg/l, for Enterococcus faecalis 2 mg/l and for Enterococcus faecium 4 mg/l. The activity of LY146032 was in general higher than that of vancomycin. Time-kill studies showed LY146032 had higher bactericidal activity than vancomycin against a methicillin-resistant Staphylococcus aureus strain, and bactericidal activity against Enterococcus faecalis and Enterococcus faecium.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3032613     DOI: 10.1007/BF02097210

Source DB:  PubMed          Journal:  Eur J Clin Microbiol        ISSN: 0722-2211            Impact factor:   3.267


  6 in total

1.  In vitro activity of LY146032 against staphylococci, streptococci, and enterococci.

Authors:  R J Fass; V L Helsel
Journal:  Antimicrob Agents Chemother       Date:  1986-11       Impact factor: 5.191

2.  In vitro and in vivo activity of LY 146032, a new cyclic lipopeptide antibiotic.

Authors:  G M Eliopoulos; S Willey; E Reiszner; P G Spitzer; G Caputo; R C Moellering
Journal:  Antimicrob Agents Chemother       Date:  1986-10       Impact factor: 5.191

3.  In vitro activity and mechanism of action of A21978C1, a novel cyclic lipopeptide antibiotic.

Authors:  G M Eliopoulos; C Thauvin; B Gerson; R C Moellering
Journal:  Antimicrob Agents Chemother       Date:  1985-03       Impact factor: 5.191

4.  In vitro activity and human pharmacokinetics of teicoplanin.

Authors:  L Verbist; B Tjandramaga; B Hendrickx; A Van Hecken; P Van Melle; R Verbesselt; J Verhaegen; P J De Schepper
Journal:  Antimicrob Agents Chemother       Date:  1984-12       Impact factor: 5.191

5.  Evaluation of the Micur microdilution systems for antibiotic susceptibility testing of gram-negative and gram-positive bacteria.

Authors:  F Kayser; K Machka; L Wieczorek; D Banauch; W Bablok; I Braveny
Journal:  Eur J Clin Microbiol       Date:  1982-12       Impact factor: 3.267

6.  Antibacterial activity of coumermycin alone and in combination with other antibiotics.

Authors:  H C Neu; N X Chin; P Labthavikul
Journal:  Antimicrob Agents Chemother       Date:  1984-06       Impact factor: 5.191

  6 in total
  8 in total

1.  Investigation of the early killing of Staphylococcus aureus by daptomycin by using an in vitro pharmacodynamic model.

Authors:  K Vance-Bryan; T A Larson; J C Rotschafer; J P Toscano
Journal:  Antimicrob Agents Chemother       Date:  1992-10       Impact factor: 5.191

2.  Correlation of penicillin-induced lysis of Enterococcus faecium with saturation of essential penicillin-binding proteins and release of lipoteichoic acid.

Authors:  S al-Obeid; L Gutmann; R Williamson
Journal:  Antimicrob Agents Chemother       Date:  1990-10       Impact factor: 5.191

3.  Comparative in vitro activity of the new peptolide antibiotic LY146032 against staphylococci.

Authors:  G Peters; F Schumacher-Perdreau; G Pulverer
Journal:  Eur J Clin Microbiol       Date:  1987-12       Impact factor: 3.267

4.  Staphylococcus aureus ventriculitis treated with single-dose intraventricular vancomycin or daptomycin (LY146032): bacterial and antibiotic kinetics in hydrocephalic rabbits.

Authors:  C S Haworth; M W Sobieski; W M Scheld; T S Park
Journal:  Antimicrob Agents Chemother       Date:  1990-02       Impact factor: 5.191

Review 5.  Future directions in antimicrobial chemotherapy.

Authors:  R Janknegt
Journal:  Pharm Weekbl Sci       Date:  1992-08-21

6.  Early stages of in vitro killing curve of LY146032 and vancomycin for Staphylococcus aureus.

Authors:  J P Flandrois; G Fardel; G Carret
Journal:  Antimicrob Agents Chemother       Date:  1988-04       Impact factor: 5.191

7.  Impact of LY146032 on Streptococcus (Enterococcus) faecalis translocation in mice.

Authors:  S H Dougherty; D J Hentges; S W Casey; W R Thal
Journal:  Antimicrob Agents Chemother       Date:  1988-03       Impact factor: 5.191

8.  Unexpected Cell Wall Alteration-Mediated Bactericidal Activity of the Antifungal Caspofungin against Vancomycin-Resistant Enterococcus faecium.

Authors:  Christophe Isnard; Sara B Hernandez; François Guérin; Fanny Joalland; Didier Goux; François Gravey; Michel Auzou; David Enot; Pierrick Meignen; Jean-Christophe Giard; Felipe Cava; Vincent Cattoir
Journal:  Antimicrob Agents Chemother       Date:  2020-09-21       Impact factor: 5.191

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.